Norman Friedland, Executive Committee, started his legal career at Cravath, Swaine and Moore.

Friedland has more than three decades of transactional experience in public offerings, private placements, IPOs, and venture investments. He has worked with prominent venture capital funds, entrepreneurs, and firms including Hambrecht & Quist, Robertson Stephens, Montgomery Securities, First Boston, and Morgan Stanley.

He was general counsel to New York State Economic Development Corporation with responsibility for Times Square Redevelopment and the Rensselaer Technology Transfer Incubator. Friedland has advised health care- and biotech-focused venture capital funds and founding teams of life science companies, including the National Foundation for Cancer Research and a European venture with nanofluidics diagnostic technology.  He has deep expertise in Program Related Investments, giving commentary to the IRS and developing financial models using PRIs that have been evaluated by MIT’s Laboratory for Financial Engineering.

Friedland graduated from New York University School of Law, where he was a John Ben Snow Scholar and a Root-Tilden Scholar.